Variables | Non nephritis | Nephritis | Total | p | ||||
---|---|---|---|---|---|---|---|---|
Blood pressure | Average | 18 | 85.7% | 8 | 42.1% | 26 | 65.0% | 0.007* |
Hypotensive | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | ||
Hypertensive | 3 | 14.3% | 11 | 57.9% | 14 | 35.0% | ||
UOP | Average | 14 | 66.7% | 5 | 26.3% | 19 | 47.5% | < 0.001* |
Anuria | 1 | 4.8% | 2 | 10.5% | 3 | 7.5% | ||
Oliguria | 6 | 28.6% | 11 | 57.9% | 17 | 42.5% | ||
Polyuria | 0 | 0.0% | 1 | 5.3% | 1 | 2.5% | ||
Proteinuria | No | 20 | 95.2% | 0 | 0.0% | 20 | 50.0% | < 0.001* |
Yes | 1 | 4.8% | 19 | 100.0% | 20 | 50.0% | ||
Casts in urine | None | 19 | 90.5% | 8 | 42.1% | 27 | 67.5% | < 0.001* |
Granular | 1 | 4.8% | 4 | 21.1% | 5 | 12.5% | ||
Hyaline | 0 | 0.0% | 1 | 5.3% | 1 | 2.5% | ||
Mixed “Granular&Hyaline” | 1 | 4.8% | 5 | 26.3% | 6 | 15.0% | ||
Crystal | 0 | 0.0% | 1 | 5.3% | 1 | 2.5% | ||
Relative expression of GAS5 (Median [IQR]) | 0.91 [0.42–1.28] | 0.24 [0.17–0.67] | 0.52 [0.19–1.02] | 0.003* | ||||
Relative expression of MALAT1 (median [IQR]) | 3.58 [1.50–5.63] | 2.60 [1.89–4.20] | 3.13 [1.69–5.15] | 0.25 | ||||
Hb (mean ± SD) | 9.3 ± 1.9 | 8.8 ± 2.0 | 9.1 ± 1.9 | 0.38 | ||||
RBC (mean ± SD) | 3,761,905 ± 763,869 | 3,584,211 ± 977,993 | 3,677,500 ± 865,305 | 0.52 | ||||
WBC (median [IQR]) | 5600 [4400–9800] | 6790 [5600–15,000] | 6500 [4400–13,850] | 0.27 | ||||
Lymphocytes (median [IQR]) | 1300 [900–1700] | 1400 [1000–1800] | 1400 [950–1800] | 0.66 | ||||
PLT (median [IQR]) | 210,000 [135,000–295,000] | 162,000 [12,7000–218,000] | 203,500 [128,000–267,500] | 0.15 | ||||
S. creatinine (median [IQR]) | 0.9 [0.8–0.9] | 1.5 [0.9–3.2] | 0.9 [0.8–2.0] | 0.004* | ||||
cNa (mean ± SD) | 138.0 ± 4.5 | 138.6 ± 6.7 | 138.3 ± 5.6 | 0.73 | ||||
ck (mean ± SD) | 3.74 ± .56 | 3.81 ± .67 | 3.77 ± .61 | 0.71 | ||||
ANA (median [IQR]) | 52.0 [40.0–93.5] | 81.8 [45.0–133.0] | 70.8 [41.1–99.0] | 0.29 | ||||
Anti.ds.DNA (median [IQR]) | 31.6 [9.9–68.0] | 79.0 [20.0–210.0] | 38.0 [15.0–161.8] | 0.1 | ||||
C3 (median [IQR]) | 76.0 [50.0–93.0] | 77.0 [28.0–98.0] | 76.5 [40.6–95.0] | 0.76 | ||||
C4 (median [IQR]) | 11.0 [8.0–22.0] | 12.0 [7.0–29.4] | 12.0 [7.5–27.1] | 0.48 | ||||
SLEDAI_2K.Score (median [IQR]) | 20.0 [14.0–29.0] | 43.0 [28.0–55.0] | 28.5 [19.5–48.0] | 0.001* | ||||
Biopsy class | Non | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | |
Class 1 | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | ||
Class 2 | 0 | 0.0% | 1 | 5.3% | 1 | 5.3% | ||
Class 3 | 0 | 0.0% | 2 | 10.5% | 2 | 10.5% | ||
Class 4 | 0 | 0.0% | 12 | 63.2% | 12 | 63.2% | ||
Class 5 | 0 | 0.0% | 3 | 15.8% | 3 | 15.8% | ||
Class 4-5 | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | ||
Class 6 | 0 | 0.0% | 1 | 5.3% | 1 | 5.3% | ||
Biopsy.AI (median [IQR]) | . | 5.5 [5.0–8.0] | - | |||||
Biopsy.CI (median [IQR]) | . | 3.5 [1.5–6.0] | - |